Named Patient Program (NPP) in Kuwait
How the named patient program (npp) pathway operates in Kuwait.
About Named Patient Program (NPP)
The foundational pathway for providing individual patients access to drugs not yet registered in their country.
How Named Patient Program (NPP) works in Kuwait
Kuwait's Ministry of Health operates a Personal Import pathway for specialty drugs not registered locally, typically through a hospital pharmacy with physician attestation.
Patients in Kuwait seeking access under Named Patient Program (NPP) typically follow this flow: a licensed physician in Kuwait issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Kuwait
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.